Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial
-
* Corresponding author: Robert D Sanders robert.sanders@ic.ac.uk
Critical Care 2010, 14:R38 doi:10.1186/cc8916
See related commentary by Kress, http://ccforum.com/content/14/3/164 and related letter by Quintin, http://ccforum.com/content/14/4/429
Evaulated on
Faculty of 1000
Accesses
- Last 30 days: 182 accesses
- Last 365 days: 2195 accesses
- All time: 8110 accesses
Cited by
BioMed Central: 4 citations
|
Article selection
Pratik P Pandharipande, Robert D Sanders, Timothy D Girard, Stuart McGrane, Jennifer L Thompson, Ayumi K Shintani, Daniel L Herr, Mervyn Maze, E Wesley Ely, Critical Care 2011, 15:402 (14 January 2011) |
|
Letter
Alpha-2 adrenoceptor agonists and sepsis: improved survival? Luc Quintin Critical Care 2010, 14:429 (29 July 2010) |
|
Commentary
The complex interplay between delirium, sepsis and sedation John P Kress Critical Care 2010, 14:164 (14 June 2010) |
|
Commentary
Pratik Pandharipande, Arna Banerjee, Stuart McGrane, E Wesley Ely Critical Care 2010, 14:157 (20 May 2010) |